Skip to main content

Peer Review reports

From: Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

Original Submission
7 Nov 2023 Submitted Original manuscript
14 Dec 2023 Reviewed Reviewer Report
22 Dec 2023 Reviewed Reviewer Report
31 Dec 2023 Author responded Author comments - Xingya Li
1 Jan 2024 Author responded Author comments - Xingya Li
Resubmission - Version 2
31 Dec 2023 Submitted Manuscript version 2
Publishing
6 Jan 2024 Editorially accepted
5 Feb 2024 Article published 10.1186/s12885-024-11852-3

You can find further information about peer review here.

Back to article page